LONSURF

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug LONSURF contains a combination of these active pharmaceutical ingredients (APIs):

1 Trifluridine
UNII RMW9V5RW38 - TRIFLURIDINE
Read about Trifluridine
2 Tipiracil
UNII 4H59KLQ0A4 - TIPIRACIL HYDROCHLORIDE

Tipiracil helps maintain the blood concentration of trifluridine by inhibiting the enzyme thymidine phosphorylase which metabolizes trifluridine.

Read about Tipiracil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01BC59 L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC59

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 11507P, 11524M, 12033H, 12056M
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 531320090011107, 531320090011207, 531320090011307, 531320090011407
Country: CA Health Products and Food Branch Identifier(s): 02472104, 02472112
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 5189-MEE-0620, 5190-MEE-0620
Country: EE Ravimiamet Identifier(s): 1716319, 1716320, 1716331, 1716342, 1716353, 1716364
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 1161096001, 1161096003, 1161096004, 1161096006
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 057979, 158698, 389330, 516182
Country: FR Base de données publique des médicaments Identifier(s): 65185956, 69681469
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 329756, 329757, 329761, 329762
Country: HK Department of Health Drug Office Identifier(s): 65360, 65361
Country: IE Health Products Regulatory Authority Identifier(s): 88850, 88851, 88852, 88853
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8802, 8803
Country: JP 医薬品医療機器総合機構 Identifier(s): 4299100F1026, 4299100F2022
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1080198, 1080199, 1080200, 1080201, 1080202, 1080203
Country: NL Z-Index G-Standaard, PRK Identifier(s): 137510, 137529
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100370700, 100370716
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W63841001, W63841002, W63842001, W63842002
Country: SG Health Sciences Authority Identifier(s): 15491P, 15494P
Country: US FDA, National Drug Code Identifier(s): 64842-1020, 64842-1025

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.